A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit.
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Antimicrobial de-escalation (ADE) is a strategy to reduce the spectrum of antimicrobials and aims to prevent the emergence of bacterial resistance. We present a systematic review describing the definitions, determinants and outcomes associated with ADE. We included 2 randomized controlled trials and 12 cohort studies. There was considerable variability in the definition of ADE. It was more frequently performed in patients with broad-spectrum and/or appropriate antimicrobial therapy (P= .05 to .002), when more agents were used (P= .002), and in the absence of multidrug-resistant pathogens (P< .05). Where investigated, lower or improving severity scores were consistently associated with ADE (P= .04 to <.001). The pooled effect of ADE on mortality is protective (relative risk, 0.68; 95% confidence interval, .52-.88). Because the determinants of ADE are markers of clinical improvement and/or of lower risk of treatment failure this effect on mortality cannot be retained as evidence. None of the studies were designed to investigate the effect of ADE on antimicrobial resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most studies were observational, and there are concerns that de-escalation is used primarily in patients who are getting better, which is why the reported improved short-term mortality should be interpreted with caution [277, 279].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [279]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148 · cited 1×
“Interrater agreement was calculated with free marginal κ statistics [8].”
MethodMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“Heterogeneity among studies was evaluated using the χ(2) test based on the Cochran Q statistic and quantified by the I(2) value [9].”
MethodMeta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 4×
“by DerSimonian and Laird [10], with the Egger test used for publication bias.”
MethodInfluentialCochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
(2014) · Medical Entomology and Zoology · Cited by 17,633
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
SINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032 · cited 1×
“has been studied for shortening treatment [27], to date there is no evidence of this for ADE because none of the published studies was designed to evaluate this variable.”
BackgroundGarnacho-Montero, J., Gutiérrez-Pizarraya, A., Escoresca-Ortega, A., Corcia-Palomo, Y., Fernández-Delgado, E., Herrera-Melero, I., Ortiz-Leyba, C., & Márquez-Vácaro, J. A. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3077-7 · Cited by 389 · cited 12×
“GarnachoMontero et al [22] 2014 No specific antimicrobials described Yes Yes No Yes Not ranked Once culture results were available”
BackgroundMethodResultInfluentialSelf-citation
Research works printed but not linked: 1
- 5. Effective Practice and Organisation of Care (EPOC). EPOC resources for review authors. Oslo, Norway: Norwegian Knowledge Centre for the Health Services; 2014 . Available at: http://epoc.cochrane.org/epoc-speci fi c-resources-reviewauthors. Accessed 19 January 2016.
Cited by
Items 201–244 of 244
Klein, M.-K. (2020) · bonndoc (University of Bonn)
De-escalation of antibiotic therapy as a part of care strategy about critically ill patients
Adámková, V. (2019) · Anesteziologie a intenzivní medicína · doi:10.36290/aim.2019.047
Waisbren, S. (2021) · Federal Practitioner · doi:10.12788/fp.0101
Zaoutis, T. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732104970.793549917
Calandra, T., & Guery, B. P. (2018) · Springer eBooks · doi:10.1007/978-3-319-73506-1_12
Antimicrobial stewardship program in critical care medicine: What is going on? Who gives more?
Zaragoza, R., & LLetí, A. C. C. (2018) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2017.10.011
Humacayo, F. S., Possagno, G. C. H., & Miyoshi, E. (2022) · Research Society and Development · doi:10.33448/rsd-v11i14.36637 · Cited by 1
Avoiding pitfalls in antibiotic therapy: the antibiotic stewardship approach
Huppertz-Thyssen, M., & Saavedra, C. R. (2022) · Magna Scientia UCEVA · doi:10.54502/msuceva.v2n2a1
Aldardeer, N. F., Shukairi, A. A., Nasser, M. E., Musawa, M. A., Kalkatawi, B. S., Alsahli, R. M., Ramdan, A. M. E., Qushmaq, I. A., & Aldhaeefi, M. (2023) · Dr Sulaiman Al Habib Medical Journal · doi:10.1007/s44229-023-00027-0
Empirical Antibiotic Therapy: De-escalation Demystified
Chacko, J., Pawar, S., Seppelt, I., & Brar, G. (2023) · Springer eBooks · doi:10.1007/978-981-19-9940-6_42
Willems, J., Heyndrickx, A., Schelstraete, P., Gadeyne, B., Cock, P. A. J. G. D., Vandendriessche, S., & Depuydt, P. O. (2024) · Scientific Reports · doi:10.1038/s41598-024-51986-9
“Though widely applied, effects on antimicrobial resistance have not been demonstrated so far 6,7 .”
BackgroundPehlivanlı, A., Özgün, Ç., Sasal-Solmaz, F. G., Yüksel, D., Başgut, B., Ozcelikay, A. T., & Ünal, N. (2024) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2023-004053
Ibrahim, N. A., Makmor‐Bakry, M., Ishak, S., Tahir, N. A. M., & Shah, N. M. (2025) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.20654
Kapmaz, M., Keske, Ş., Tekin, S., Doğan, Ö., İrkören, P., Ataç, N., Vatansever, C., Albayrak, Ö., Genç, Z., Madran, B., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14080800
“On the other hand, some studies have found a non-significant link between ADE and mortality [24].”
Waagsbø, B., Tranung, M., Damås, J. K., & Heggelund, L. (2022) · Figshare · doi:10.6084/m9.figshare.21340490
Yoshida, H., Motohashi, T., Bus, L. D., De Waele, J., Takaba, A., Kuriyama, A., Kobayashi, A., Tanaka, C., Hashi, H., Hashimoto, H., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21251621
Self-citationZhao, K., Zhang, Z.-D., liang, Y., Wang, Y., & Cai, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26608494
Sieswerda, E., Bax, H. I., Hoogerwerf, J. J., de Boer, M. G. J., Boermeester, M. A., Bonten, M. J. M., Dekker, D., van Wijk, R. G., Juffermans, N. P., Kuindersma, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20479548
Self-citationWaagsbø, B., Tranung, M., Damås, J. K., & Heggelund, L. (2022) · Figshare · doi:10.6084/m9.figshare.21340487
Relevancia clínica de la monitorización de niveles de Linezolid en el paciente crítico
Muñoz-Bermúdez, R. (2021) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Esteve-Palau, E., & de Medicina, U. A. D. B. D. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Ruiz, L. D. (2022) · Docta Complutense (Universidad Complutense de Madrid)
Antibiotics and infection in the intensive care unit : the importance of frailty
Bernardino, M. M. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
awad, A. A., Hammour, K. A., Abuawad, A., Zawiah, M., & Farha, R. K. A. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001379
Kerala, I. I. D. P. I., & Warrier, A. R. (2025) · doi:10.61440/jidt.2026.v4.55
Husain, M. K., Itani, K., Dongre, S., Winarso, E., Padhye, P. S., Ak, R. S. E. M., Laheri, V. K., & Saeed, W. (2026) · International Journal of Accounting and Economics Studies · doi:10.14419/cktc0161
Κλειούση, Ε. Β. (2025) · University of Thessaly Institutional Repository (University of Thessaly)
Koneoppiminen antibioottiresistenssikriisin päätöksenteossa
Peltomäki, J. (2024) · Tampere University Institutional Repository (Tampere University)
Manejo de las infecciones graves por bacterias gramnegativas multirresistentes en el enfermo crítico
Garnacho‐Montero, J., Adriaensens-Pérez, M., Aldabó-Pallás, T., Anaya-Carrión, N., Ojeda, D., Cantón‐Bulnes, M. L., PASCALE, G. D., Fernández-Delgado, E., Póvoa, P. M. S. R., Galleymore, P. R., et al. (2026) · Medicina Intensiva · doi:10.1016/j.medin.2026.502443
Self-citationAntibiotic Stewardship for the Intensivist
Hawes, A. M., & Cosgrove, S. E. (2026) · Critical Care Clinics · doi:10.1016/j.ccc.2026.01.004
熱傷患者における感染症治療戦略のde-escalation実施に関する有用性の評価
小濱, 弥. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.15006/32665a6069
Ohnuma, T., Fuller, M., Balamurugan, P., Moehring, R. W., Krishnamoorthy, V., Raghunathan, K., & Treggiari, M. M. (2026) · Journal of Critical Care · doi:10.1016/j.jcrc.2026.155646
Meschiari, M., Onorato, L., Albertini, M., Fontana, B., Menozzi, V., Cantergiani, S., Simion, M., Santoro, A., Franceschini, E., Orlando, G., et al. (2026) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlag148
Zhang, L., & Ye, H. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-14080-1
“Specific criteria, consistent with established antimicrobial stewardship principles [15], included the following: (1) switching from an empirical regimen with unnecessary anti-pseudomonal, anti-MRSA, anti-enterococcal, or antifungal coverage to a culture-and susceptibility-confirmed regimen with a…”
KILIÇ, E. K., Demircan, Ş. A., Eroğlu, Ş. B., Üçer, Ş., Cesur, S., Şengü, B., Kaymak, Ç., Karakoc, A. E., Hatipoğlu, Ç. A., Ertem, G. T., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10340423/v1
Tian, L., Xu, S., Xie, X., Wang, M., & Huang, L. (2026) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2026.1902608
“Antimicrobial stewardship is among the most cost-effective strategies for safeguarding the microbiome, targeting Driver 3 — antibiotic-mediated niche clearance (79, 80).”
Pellejero-Sagastizábal, G., Morte-Romea, E., Girón-Ortega, J. A., Paño‐Pardo, J. R., Guerrero, R. F., Guerrero, F., de Oca, M. M., Jiménez-Jorge, S., Palacios-Baena, Z. R., Rodríguez‐Baño, J., et al. (2026) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-026-01810-y
Yamamoto, K., Edakubo, S., Fushimi, K., & Shinjo, D. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.109070
Pérez-Oliva, C., Giglio, A., & Borges-Sa, M. (2026) · Revista Española de Quimioterapia · doi:10.37201/req/235.2026
“A systematic review found reduced ICU mortality with de-escalation (RR 0.68, 95% CI 0.52–0.88) [29 ].”
InfluentialSava, M., Codru, I. R., Bereanu, A. S., Fratila, A. M., & Vintilă, B. I. (2026) · Antibiotics · doi:10.3390/antibiotics15090912
Yi, Q., & Han, K. (2026) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2026.108065
Wang, S., Liu, Y., Wang, H., Yu, Y., Luo, C., & Hu, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1993215
How to Adequately Treat Pseudomonas aeruginosa Infections
Hartlage, A. S., Reynolds, D., & Kollef, M. H. (2026) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2991-9004
Metadata
- Authors
- Tabah, A., Cotta, M. O., Garnacho-Montero, J., Schouten, J., Roberts, J. A., Lipman, J., Tacey, M., Timsit, J.-F., Leone, M., Zahar, J. R., & De Waele, J. J.
- Affiliations
- Royal Brisbane and Women's Hospital (AU)
- The University of Queensland (AU)
- Canisius-Wilhelmina Ziekenhuis (NL)
- Queensland University of Technology (AU)
- The Royal Melbourne Hospital (AU)
- Centre Hospitalier Universitaire d'Angers (FR)
- Corresponding author
- Tabah, Alexis
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-12-23
- Volume
- 62
- Issue
- 8
- Pages
- 1009-1017
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2253853790
- Cited by
- 220
- References
- 29
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 20 · 2023: 18 · 2022: 31 · 2021: 13 · 2020: 26 · 2019: 24 · 2018: 25 · 2017: 21 · 2016: 14 · 2015: 1
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- Clinical Infectious Diseases (publishedVersion, other-oa)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
- Funders
- Pfizer
- AstraZeneca
- Gilead Sciences
- Fonds Wetenschappelijk Onderzoek
- Astellas Pharma
- Vlaamse regering
- European Society of Intensive Care Medicine
- Medical Research Council
- National Health and Medical Research Council (1099452, 1048652)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antibiotic de-escalation, intensive care unit, antimicrobial resistance, mortality, broad-spectrum antimicrobial therapy, multidrug-resistant pathogens, severity scoring, clinical outcomes
- MeSH terms
- Anti-Bacterial Agents, Bacterial Infections, Clinical Trials as Topic, Cross Infection, Drug Resistance, Microbial, Humans, Intensive Care Units, Severity of Illness Index, Cohort Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.